Drug discovery and development in tuberculosis

In the history drugs are discovered through the active ingredients from age old remedies, but during the present day’s disease are controlled by molecular and physiological level. The healthy approach towards discovering new drugs also measures to reduce the prolonged clinical development of new drugs.it involves the details about the preclinical and clinical trials of tuberculosis. Antibiotic drugs became shortage due to multiple drug resistance which is main cause of tuberculosis. New drug discovery uses the inactive bacteria to develop new drug for tuberculosis. Mycobacterium is resistant to most the antibiotics. To achieve the shorter duration therapy it is expected to destroy the sub population of mycobacterium.



<p style="&quot;margin-left:" 58.5pt;="" text-align:="" justify;"="">

  • Clinical trials
  • TB Drug development
  • Optimizing drug activity against pathogen
  • TB drug pipeline
  • TB therapy

Related Conference of Drug discovery and development in tuberculosis

February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
April 27-28, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

September 28-29, 2020

World Congress on Infectious Diseases and Rare Diseases

Osaka, Japan
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria

Drug discovery and development in tuberculosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in